ARTICLE

DRUG VS SELFCARE MANAGEMENT OF GESTATIONAL DIABETES MELLITUS KNOWLEDGE AND PRACTICES OF WOMEN ATTENDING ANTENATAL CLINICS OF FAISALABAD

  1. HOME
  2. ARTICLE

11 Pages : 80-88

http://dx.doi.org/10.31703/gdddr.2023(VIII-II).11      10.31703/gdddr.2023(VIII-II).11      Published : Jun 2023

Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad

Abstract

    Gestational diabetes mellitus is a significant and growing global health issue. Objectives: To assess the knowledge of women attending antenatal clinics in Faisalabad regarding GDM and its self‐care management practices. Methodology: A descriptive cross‐sectional study. The study's duration was 4 months from February 2023 to May 2023 and study setting areas included Allied Hospital Faisalabad and District Head Quatre Hospital Faisalabad. The population included women attending antenatal clinics in Faisalabad regarding GDM and its self‐care management practices were assessed using a self‐structured questionnaire. Results: Among the total of 384 participants, the majority (253; 65.9%) were less than 30 years old. Mostly (365; 95.1%) women are married. Mostly (201; 52.3%) are 26‐30 years old during marriage. Mostly (160; 41.7%) are 1‐5 Years have passed years of marriage. The results revealed that the majority of the participant nurses had an average level of practice 49.99%, below average level of attitude 22.52% and a satisfactory level of knowledge, 82.33%.

    Knowledge GDM, Self‐Care and Management Practices

    (1) Maham Riaz
    General Nurse, Children Hospital Faisalabad, Punjab, Pakistan.
    (2) Rabia Fazeelat
    General Nurse, Children Hospital Faisalabad, Punjab, Pakistan.
    (3) Shazia Kousar
    General Nurse, Allied Hospital Faisalabad, Punjab, Pakistan.
    (4) Noor Fatima
    General Nurse, Aziz Fatima Hospital, Faisalabad, Punjab, Pakistan.
Fulltext PDF

References

  • Suri, S. S. H., &Fenniri, B. (2007) Singh, Nanotechnology-based drug delivery systems, J.Occup. Med. Toxicol. 1, 2–16.
  • Roco, M. C. (2003). Nanotechnology: convergence with modern biology and medicine, Curr. Opin. Biotechnol. 14, 337–346.
  • Torchilin, V. P. (2008). Nanotechnology in Drugs, second ed. Imperial College Press,London,
  • Sahoo, S. K. V. (2008). Labhasetwar, Nanotech approaches to drug delivery and imaging, Drug Discov. Today 8, 1112–1120.
  • Couvreur, P. C. (2006). Vauthier, Nanotechnology: intelligent design to treat complex disease, Pharm. Res. 23, 1417–1450.
  • Kumar, R. M. N. (2000). Nano and microparticles as controlled drug delivery devices, J.Pharm. Pharm. Sci. 3, 234–258.
  • Liu, Z, Y. Jiao, Y. Wang, C. Zhou, Z. Zhang. (2008). Polysaccharides-based nanoparticles as drug delivery systems, Adv. Drug Deliv. Rev. 60, 1650–1662.
  • Fernandez-Urrusuno, P., Calvo, C., Remunan- Lopez, J., L. & Vila-Jato, M. J. (1999). Alonso, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res. 16, 1576–1581.
  • Farrugia, M. J. (1999). Groves, the activity of unloaded gelatin nanoparticles on murine B16-F0 melanoma growth in vivo, Anticancer. Res. 19, 1027–1031.
  • Fattal, C. Vauthier, I. Aynie, Y. Nakada, G. Lambert, C. Malvy, P. (1998). Couvreur, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides, J. Control. Release 53, 137– 143.
  • Breunig, S. Bauer, A. (2008). Goepferich, Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68, 112–128
  • Kuijpers, P.B. van Wachem, M.J.A. van Luyn, L.A. Brouwer, G.H.M. Engbers, J. Krijgsveld, (2000). In vitro and in vivo evaluation of gelatin chondroitin sulphate hydrogels for controlled release of antibacterial proteins, Biomaterials 21, 1763–1772.
  • Elzoghby, W.S. Abo El-Fotoh, N. A. (2011). Elgindy, Casein-based formulations as promising controlled release drug delivery systems, J. Control. Release 153, 206–216.
  • Vandelli, F. Rivasi, P. Guerra, F. Forni, R. (2001). Arletti, Gelatin microspheres crosslinked with d, l-glyceraldehyde as a potential drug delivery system: preparation, characterization, in vitro and in vivo studies, Int. J. Pharm. 215, 175–184.
  • Sahin, H. Selek, G. Ponchel, M.T. Ercan, M.A. Sargon, A. Hincal, H.S. (2002). Kas, Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres, J. Control. Release 82, 345–358.
  • Langer, S. Balthasar, V. Vogel, N. Dinauer, H. von Briesen, D. (2003). Schubert Optimization of the preparation process for human serum albumin (HSA) nanoparticles, Int. J. Pharm. 257, 169–180.
  • Rubino, R. Kowalsky, J. (1993). Swarbrick, Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking and drug release, Pharm. Res. 10, 1059–1065.
  • Kommareddy, M. (2005). Amiji, Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione, Bioconjug. Chem. 16, 1423–1432.
  • Azarmi, X. Tao, H. Chen, Z. Wang, W.H. Finlay, R. (2006). Löbenberg, W.H. Roa, Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles, Int. J. Pharm. 319, 155–161.
  • Kratz, I. Fichtner, P. Schumarcher, T. (1997). Roth, H.H. Feibig, C. Unger, Antitumoractivity of acid labile transferrin and albumin doxorubicin conjugates in vitro and in vivo human tumor xerograft models, Eur. J. Cancer 33, S175.
  • Rahimnejad, M. Jahanshahi, G.D. (2006). Najafpour, Production of biological nanoparticles from bovine serum albumin for drug delivery, Afr. J. Biotechnol.5, 1918–1923
  • Fasano, M., Curry, S., & Terreno, E. (2005). The extraordinary ligand binding properties human serum albumin. IUBMB Life 57, 787– 79
  • Droge, W., Schulze-Osthoff, K., & Mihm, S, (1994). Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J, 8, 1131–1138
  • Stohl, W. (1996). Elliot JE: In vitro inhibition by intravenous immunoglobulin of human cell- dependent B cell differentiation induced by staphylococcal superantigens. Clin Immunol Immunopathol, 79, 122–133
  • Crow, A. R., Song, S., & Semple, J. W. (2001). IVIg inhibits reticuloendothelial system function and ameliorates murine passive- immune thrombocytopenia independent of antidiotype reactivity. Br J Haematol, 115, 679–686
  • Ephrem, A., Chamat, S., & Miquel, C, (2008). Expansion of CD4+ CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood, 111, 715–722
  • Kragh-Hansen, U. (2013). Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes. Biochim Biophys Acta , 1830(12), 5535-44
  • Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012). Albuminbased nanoparticles as potential controlled release drug delivery systems. J Control Release, 157(2), 168-82.
  • Liumbruno, G. M., Bennardello, F., Lattanzio, A., Piccoli, P., & Rossettias, G. (2009). Recommendations for the use of albumin and immunoglobulins. Blood Transfus, 7(3):216- 34
  • Dugaiczyk, A., Law, S. W., & Dennison, O. E. (1982). Nucleotide sequence and the encoded amino acids of human serum albumin mrna. Proc Natl Acad Sci USA , 79(1):71-5
  • Gerety, R. J., & Aronson, D. L. (1982). Plasma derivatives and viral hepatitis. Transfusion, 22(5):347-51.
  • Clowes, G. H. J., Vucinic, M., & Weidner, M. G. (1966). Circulatory and metabolic alterations associated with survival or death in peritonitis: Clinical analysis of 25 cases. Ann Surg, 163(6):866-85
  • Chen, Z., He, Y., Shi, B., & Yang, D. (2013). Human serum albumin from recombinant DNA technology:Challenges and strategies. Biochim Biophys Acta, 1830(12):5515-25
  • Raoufinia, R., Mota, A., Nozari, S., Aghebati, M. L., Balkani, S., & Abdolalizadeh, J. (2016). A methodological approach for purification and characterization of human serum albumin. J Immunoassay Immunochem, 37(6):623-35
  • He, Y., Ning, T., Xie, T., Qiu, Q., Zhang, L., & Sun, Y. (2011). Large-scale production offunctional human serum albumin from transgenic rice seeds. Proc Nat Acad Sci USA, 108(47):19078- 83
  • Raoufinia, R., Mota, A., Nozari, S., Aghebati, M. L., Balkani, S., & Abdolalizadeh, J. (2016). AMethodological Approach for Purification and Characterization of Human Serum Albumin.J. Immunoassay Immunochem. 37(6), 623–635
  • Hage, D. S., Anguizola, J. A., Bi, C., Li, R., Matsuda, R., & Papastavros, E, (2012). Pharmaceutical and biomedical applications of affinitychromatography: Recent trends and developments. J Pharm Biomed Anal, 69, 93- 105
  • Abdolalizadeh, J., Nouri, M., Zolbanin, J. M., Barzegari, A., Baradaran, B., & Barar, J. (2013). Targeting cytokines: Production and characterization of antiTNF-alpha scFvs by phage display technology. Curr Pharm Des, 19(15), 2839-47.
  • Abdolalizadeh, J., Majidi, Z. J., Nouri, M., Baradaran, B., Movassaghpour, A., & Farajnia, S. (2013). Affi nity purification of tumor necrosis factoralpha expressed in raji cells by Produced scFvantibody coupled CNBr-activated sepharose. Adv Pharm Bull, 3(1):1923.
  • Abdolalizadeh, J., Nouri, M., Zolbanin, J. M, Baradaran, B., Barzegari, A., & Omidi, Y. (2012). Downstream characterization of anti- TNF-alpha single chain variable fragment antibodies. Hum Antibodies, 21(1-2), 41-8
  • Cuatrecasas, P., Wilchek, M., & Anfinsen, C. B. (1968). Selective enzyme purification byaffinity chromatography. Proc Natl Acad Sci USA, 61(2), 636-43
  • Moore, S., & Stein, W. H. (1956). Column chromatography of peptides and proteins. Adv. Protein Chem., 11, 191-236.
  • William, W. (2009). Ward and Gavin Swiatek, Protein Purification, Current Analytical Chemistry, 5,000-000
  • Kovacs, A., & Guttman, A. (2013). Medicinal chemistry meets proteomics: Fractionation of the human plasma proteome. Curr Med Chem, 20(4), 483-90
  • Vasileva, R., Jakab, M., & Hasko, F. (1981). Application of ionexchange chromatography for the production of human albumin. J Chromatogr, 216, 279-84
  • Abdolalizadeh, J., Majidi, J., & Farajnia, S. (2008). Production and purification of polyclonal antibody against human kappa light chain. J Biol Sci, 8(3), 683-6.
  • Aghebati, M. A. (2013). Large scale generation and characterization of anti-human cd34 monoclonal antibody in ascetic fluid of balb/c mice. Adv Pharm Bull, 3(1), 211-6
  • Frerick, C., Kreis, P., Gorak, A., & Melzner, D. (2006). Simulation and optimisation of the downstream process for purification of human serum albumin by using ion exchange membrane adsorbers. Desalination, 200 (1-3), 468-9
  • Frerick, C., Kreis, P., Gorak, A., Tappe, A., & Melzner, D. (2008). Simulation of a human serum albumin downstream process incorporating ion-exchange membrane adsorbers. Chem Eng Process, 47(7), 1128-38
  • Ramin, R., Ali, M., Neda, K., Fatemeh, S., Sara, S., & Jalal, A. (2016). Overview of protein ad its purification. Adv pharm bull, 6(4), 495-507.
  • Denizli, A. (2011). Plasma fractionation: Conventional and chromatographic methods for albumin purification. Hacettepe J Biol Chem 39(4), 315-41.

Cite this article

APA

    APA : Riaz, M., Fazeelat, R., & Kousar, S. (2023). Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad. Global Drug Design & Development Review, VIII(II), 80-88. https://doi.org/10.31703/gdddr.2023(VIII-II).11

CHICAGO

    CHICAGO : Riaz, Maham, Rabia Fazeelat, and Shazia Kousar. 2023. "Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad." Global Drug Design & Development Review, VIII (II): 80-88 doi: 10.31703/gdddr.2023(VIII-II).11

HARVARD

    HARVARD : RIAZ, M., FAZEELAT, R. & KOUSAR, S. 2023. Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad. Global Drug Design & Development Review, VIII, 80-88.

MHRA

    MHRA : Riaz, Maham, Rabia Fazeelat, and Shazia Kousar. 2023. "Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad." Global Drug Design & Development Review, VIII: 80-88

MLA

    MLA : Riaz, Maham, Rabia Fazeelat, and Shazia Kousar. "Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad." Global Drug Design & Development Review, VIII.II (2023): 80-88 Print.

OXFORD

    OXFORD : Riaz, Maham, Fazeelat, Rabia, and Kousar, Shazia (2023), "Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad", Global Drug Design & Development Review, VIII (II), 80-88

TURABIAN

    TURABIAN : Riaz, Maham, Rabia Fazeelat, and Shazia Kousar. "Drug vs Self-Care Management of Gestational Diabetes Mellitus: Knowledge and Practices of Women Attending Antenatal Clinics of Faisalabad." Global Drug Design & Development Review VIII, no. II (2023): 80-88. https://doi.org/10.31703/gdddr.2023(VIII-II).11